Form 4 for VIR Vir Biotechnology, Inc.
Accepted 2026-04-30 17:43:20 ET · period of report 2026-04-29 · accession 0001628280-26-029041 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-30 17:43 | 2026-04-29 | VIR | De Backer Marianne | Pres, CEO, Dir | J - Other | $0.00 | -233.5K | 714.6K | -25% | $0 | |
| I | 2026-04-30 17:43 | 2026-04-29 | VIR | De Backer Marianne | Pres, CEO, Dir | J - Other | $0.00 | +233.5K | 286.6K | +440% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-29 | J | D | 233,532 | $0.00 | 714,613 | D | — | — | (F1) Transfer without consideration for tax and estate planning purposes. |
| 2 | Common | Common Stock | 2026-04-29 | J | A | 233,532 | $0.00 | 286,650 | I See Footnote | — | — | (F1) Transfer without consideration for tax and estate planning purposes. (F2) The shares are held in the name of the Ureel-De Backer Family Trust, of which the Reporting Person and her spouse are Trustees. |